Venetoclax plus arsenic and all-trans retinoic acid in patients with relapsed/refractory acute promyelocytic leukemia by Bingqian Jiang, Hongyan Tong, Min Yang, Huafeng Wang, Shanshan Suo, Chenying Li, Liping Mao, Xingnong Ye, Haitao Meng, Wenjuan Yu, Jie Jin, Yinjun Lou

Get full text

Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera by Albert Qin, Kazuya Shimoda, Shanshan Suo, Rongfeng Fu, Keita Kirito, Daoxiang Wu, Jason Liao, Haoqi Chen, Lei Wu, Xia Su, Yucheng Gao, Toshiaki Sato, Yaning Li, Jingjing Zhang, Weihong Shen, Wei Wang, Lei Zhang, Jie Jin, Norio Komatsu

Get full text

Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study by Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Aili He, Qingchi Liu, Xin Du, Sujun Gao, Yarong Li, Yan Li, Yuqing Chen, Wen Wu, Huanling Zhu, Guangsheng He, Mei Hong, Qian Jiang, Zhongxing Jiang, Hongmei Jing, Jishi Wang, Na Xu, Lingling Yue, Cuiping Zheng, Zeping Zhou, Chenghao Jin, Xin Li, Lin Liu, Yajing Xu, Dengshu Wu, Feng Zhang, Jin Zhang, Liqing Wu, Hewen Yin, Binhua Lv, Zhijian Xiao, Jie Jin

Get full text